Cohort B: paridiprubart Clinical Trials (2026): 2 Studies for Acute Respiratory Distress Syndrome & Acute Respiratory Distress Syndrome (ARDS)
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
2 Cohort B: paridiprubart clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Acute Respiratory Distress Syndrome & Acute Respiratory Distress Syndrome (ARDS)) and 800 total planned enrollment. 2 Cohort B: paridiprubart clinical trials are actively recruiting at 53 U.S. sites across 20 states. Most recent activity: NCT06701669 (Sep 2028).
Where to Participate: All Cohort B: paridiprubart Trial Sites in the U.S. (53 sites across 20 states)
Every actively recruiting Cohort B: paridiprubarttrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | Community Regional Medical Center | Fresno93721-1324 | NCT06701669 | Map |
| CA | Community Regional Medical Center | Fresno93721-1324 | NCT06703073 | Map |
| CA | Long Beach Memorial Medical Center | Long Beach90806-1701 | NCT06701669 | Map |
| CA | Long Beach Memorial Medical Center | Long Beach90806-1701 | NCT06703073 | Map |
| CA | University of California Irvine Medical Center | Orange92868-3201 | NCT06701669 | Map |
| CA | University of California Irvine Medical Center | Orange92868-3201 | NCT06703073 | Map |
| CA | University of California Davis Medical Center - Pulmonary Medicine | Sacramento95816-4300 | NCT06701669 | Map |
| CA | University of California Davis Medical Center - Pulmonary Medicine | Sacramento95816-4300 | NCT06703073 | Map |
| CO | Denver Health Hospital and Authority | Denver80204-4532 | NCT06701669 | Map |
| DC | MedStar Washington Hospital Center | Washington D.C.20010-3017 | NCT06701669 | Map |
| DC | MedStar Washington Hospital Center | Washington D.C.20010-3017 | NCT06703073 | Map |
| FL | Nova Clinical Research | Bradenton34209-4617 | NCT06701669 | Map |
| FL | Nova Clinical Research | Bradenton34209-4617 | NCT06703073 | Map |
| FL | North Florida / South Georgia Veterans Health System | Gainesville32608-1135 | NCT06701669 | Map |
| FL | North Florida / South Georgia Veterans Health System | Gainesville32608-1135 | NCT06703073 | Map |
| FL | Sarasota Memorial Hospital | Sarasota34239 | NCT06701669 | Map |
| FL | Sarasota Memorial Hospital | Sarasota34239 | NCT06703073 | Map |
| ID | St. Luke's Boise Medical Center | Boise83712-6241 | NCT06701669 | Map |
| ID | St. Luke's Boise Medical Center | Boise83712-6241 | NCT06703073 | Map |
| IL | OSF Saint Francis Medical Center- | Peoria61637-0001 | NCT06701669 | Map |
| IL | OSF Saint Francis Medical Center- | Peoria61637-0001 | NCT06703073 | Map |
| MA | Lahey Hospital and Medical Center | Burlington01805-0001 | NCT06701669 | Map |
| MA | Lahey Hospital and Medical Center | Burlington01805-0001 | NCT06703073 | Map |
| MI | University of Michigan Hospital | Ann Arbor48109-5000 | NCT06701669 | Map |
| MI | University of Michigan Hospital | Ann Arbor48109-5000 | NCT06703073 | Map |
| MI | Henry Ford Health Hospital | Detroit48202-2608 | NCT06701669 | Map |
| MI | Henry Ford Health Hospital | Detroit48202-2608 | NCT06703073 | Map |
| MN | Mayo Clinic | Rochester55905-0001 | NCT06701669 | Map |
| MN | Mayo Clinic | Rochester55905-0001 | NCT06703073 | Map |
| NJ | Robert Wood Johnson Medical School | New Brunswick08901-1928 | NCT06701669 | Map |
| NJ | Robert Wood Johnson Medical School | New Brunswick08901-1928 | NCT06703073 | Map |
| NY | Montefiore Hospital - Moses Campus | The Bronx10467 | NCT06701669 | Map |
| NY | Montefiore Hospital - Moses Campus | The Bronx10467 | NCT06703073 | Map |
| NC | University of North Carolina at Chapel Hill | Chapel Hill27599-0001 | NCT06701669 | Map |
| NC | University of North Carolina at Chapel Hill | Chapel Hill27599-0001 | NCT06703073 | Map |
| NC | Durham VA Medical Center | Durham27705-3875 | NCT06701669 | Map |
| NC | Durham VA Medical Center | Durham27705-3875 | NCT06703073 | Map |
| OH | Mercy Health - St. Vincent Medical Center | Toledo43608-2603 | NCT06701669 | Map |
| OH | Mercy Health - St. Vincent Medical Center | Toledo43608-2603 | NCT06703073 | Map |
| OK | The University of Oklahoma Health Sciences Center | Oklahoma City73104-3609 | NCT06701669 | Map |
| OK | The University of Oklahoma Health Sciences Center | Oklahoma City73104-3609 | NCT06703073 | Map |
| OR | Oregon Health and Science University | Portland97239-3011 | NCT06701669 | Map |
| OR | Oregon Health and Science University | Portland97239-3011 | NCT06703073 | Map |
| SC | Medical University of South Carolina (MUSC) | Charleston29425-8908 | NCT06701669 | Map |
| SC | Medical University of South Carolina (MUSC) | Charleston29425-8908 | NCT06703073 | Map |
| TN | Vanderbilt University Medical Center | Nashville37232-0004 | NCT06701669 | Map |
| TN | Vanderbilt University Medical Center | Nashville37232-0004 | NCT06703073 | Map |
| TX | Baylor All Saints Medical Center | Fort Worth76104-4110 | NCT06701669 | Map |
| TX | Baylor All Saints Medical Center | Fort Worth76104-4110 | NCT06703073 | Map |
| UT | Intermountain Medical Center | Murray84107-5701 | NCT06701669 | Map |
| UT | Intermountain Medical Center | Murray84107-5701 | NCT06703073 | Map |
| WA | Swedish Medical Center | Seattle98122-4379 | NCT06701669 | Map |
| WA | Swedish Medical Center | Seattle98122-4379 | NCT06703073 | Map |
Cohort B: paridiprubart clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P2 | 2 | 2 |
Recruiting Cohort B: paridiprubart clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT06701669 | JUST BREATHEJUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart | P2 | Acute Respiratory Distress Syndrome (ARDS) | 200 | Jun 2025 |
| NCT06703073 | JUST BREATHEJUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record) | P2 | Acute Respiratory Distress Syndrome (ARDS) | 600 | Jun 2025 |
Cohort B: paridiprubart pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| JUST BREATHE | NCT06701669 | P2 | recruiting | Acute Respiratory Distress Syndrome (ARDS) | 200 | — |
| JUST BREATHE | NCT06703073 | P2 | recruiting | Acute Respiratory Distress Syndrome (ARDS) | 600 | PMID 40028879 |
All Cohort B: paridiprubart trials (2)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06701669 | JUST BREATHE | JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart | P2 | recruiting | 200 | PPD Development, LP | Jun 2025 |
| NCT06703073 | JUST BREATHE | JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record) | P2 | recruiting | 600 | PPD Development, LP | Jun 2025 |
Cohort B: paridiprubart clinical trials: frequently asked questions
- How many Cohort B: paridiprubart clinical trials are there?
- 2 Cohort B: paridiprubart clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants.
- Are Cohort B: paridiprubart clinical trials recruiting in 2026?
- Yes — 2 Cohort B: paridiprubart trials are actively recruiting in 2026, with 53 U.S. sites across 20 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is Cohort B: paridiprubart being studied for?
- Cohort B: paridiprubart is being studied for Acute Respiratory Distress Syndrome, Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome). The trials are grouped by indication on this page.
- What phase is Cohort B: paridiprubart in?
- Cohort B: paridiprubart clinical trials span 2 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Cohort B: paridiprubart clinical trials?
- The lead sponsor across the most Cohort B: paridiprubart trials is PPD Development, LP. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Cohort B: paridiprubartas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: